US Closed System Transfer Devices Market

The US closed system transfer devices market is projected to reach USD 0.87 billion by 2031 from USD 0.66 billion in 2026, at a CAGR of 5.5%. The US closed system transfer devices (CSTD) market is growing primarily due to increasing emphasis on protecting healthcare workers from occupational exposure to hazardous drugs, particularly antineoplastic medicines. NIOSH recommends CSTDs as an engineering control to limit exposure during hazardous-drug compounding and administration, while USP <800> requires CSTDs for administering NIOSH-listed antineoplastic hazardous drugs when the dosage form allows. The increasing implementation of hazardous-drug handling standards across hospitals, oncology centers, and pharmacies is therefore supporting CSTD adoption. In addition, growing awareness of drug contamination, vapor escape, and needlestick risks is encouraging healthcare facilities to adopt more comprehensive closed-transfer systems.

Some of the major players in the US closed system transfer devices market include B. Braun SE (Germany), ICU Medical Inc (US), Becton Dickinson and Company (US), Baxter (US), JMS Co., Ltd. (Japan), and EQUASHIELD Medical Ltd. (US), among others. These leading manufacturers enhance their market positions through innovation, expansion, and collaboration. They actively engage in research & development to create technologically advanced US closed system transfer devices that improve safety and efficiency during medical procedures. Additionally, many companies are expanding their businesses through partnerships and acquisitions, enabling them to broaden their product ranges and enter new geographic markets. Several firms are also pursuing organic growth by introducing new products and seeking regulatory approval for their offerings.

To know about the assumptions considered for the study download the pdf brochure

ICU Medical Inc. (US)

ICU Medical, Inc. is one of the key players in the US closed system transfer devices market due to its established oncology portfolio, comprising ChemoLock and ChemoClave, which address hazardous-drug preparation and administration across pharmacy and nursing workflows. ChemoLock uses proprietary membrane-to-membrane needle-free technology to limit hazardous-drug and vapor escape, while ChemoClave uses ISO-standard Luer-lock connections, enabling compatibility with existing needle-free connectors and infusion pumps. The company also offers a broad range of CSTD components and customized configurations, supporting different healthcare workflows. Its long-standing presence in the oncology market, FDA-cleared CSTD products, established manufacturing capabilities, and integration with its broader infusion and compounding portfolio strengthen its competitive position.

Becton Dickinson and Company (US)

Becton, Dickinson and Company (BD) is one of the key players in the US closed system transfer devices market due to its established PhaSeal franchise, which pioneered the CSTD category and has extensive adoption across hazardous-drug preparation and administration workflows. Its portfolio includes PhaSeal Optima and Texium, providing different technologies for containment and safe drug transfer. PhaSeal Optima combines vapor capture and self-sealing membrane technology to provide airtight, leakproof transfers, while also supporting compatibility with standard ISO-compliant components. BD’s FDA-cleared CSTD portfolio, established US commercial infrastructure, and ongoing transition from legacy PhaSeal products to the next-generation Optima system further strengthen its competitive position.

Market Ranking

The US closed system transfer devices market is primarily led by ICU Medical (US), which benefits from a comprehensive product portfolio and a strong regional presence. This enables high adoption rates across healthcare settings. Becton Dickinson and Company (US) plays a significant role in market growth by offering a diverse range of closed system transfer devices. EQUASHIELD Medical Ltd. (US) also holds a strong position by leveraging its regional reach and extensive product offerings. B Braun SE (Germany) further solidifies its market position by providing a range of US closed system transfer devices in the US.

Related Reports:

US Closed System Transfer Devices Market by Closing Mechanism [Push-to-Turn, Click-to-lock, Luer Lock System], Component [Female Component, Vial Access, Bag Spike], Type [Membrane-to-Membrane, Needleless], End User [Hospitals, Clinics] - Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]